Doc. 2.09-0.5
17th Stop TB Coordinating Board Meeting
November 2009
PROPOSED LIST OF INVITEES
Chairs, Stop TB Working Groups
DOTS Expansion Working Group and
Chair of STAG
Dr Jeremiah Muhwa Chakaya
Technical Expert
National Leprosy and TB Programme
Ministry of Health
P.O. Box 20781
Nairobi
Kenya
TB/HIV Working Group
Dr Diane V. Havlir
Professor of Medicine and
Chief of the HIV/AIDS Division and
Positive Health Program
University of California
Building 80, Ward 84
995 Potrero Ave
94110 - San Francisco, California
United States of America
MDR-TB Working Group
Dr Catharina (Kitty) Lambregts
-van Weezenbeek
KNCV Tuberculosis Foundation
PO Box 146
2501 CC The Hague
The Netherlands
Working Group on New TB Vaccines
Dr Michel Greco
Independent Vaccine Expert
Parteurop
41 quai Fulchiron
69005 - Lyon
France
Global Laboratory Initiative Working
Group
Dr John Ridderhof
Centers for Disease Control
1600 Clifton Road
Atlanta, GA 30333
United States of America
Working Group on New TB Diagnostics
Dr Giorgio Roscigno
Chief Executive Officer
Foundation for Innovative New Diagnostics
(FIND)
16, avenue de Budé
Geneva
Switzerland
Madhukar Pai, MD, PhD
Co-Chair
Working Group on New TB Diagnostics
& Assistant Professor & CIHR New In
IIvestigator
Dept. of Epidemiology, Biostatistics
& Occupational Health
McGill University
Working Group on new TB Drugs
Dr Mel Spigelman
Global Alliance for TB Drug Development
40 Wall Street
10005 - New York, NY, NY
United States of America
Regional Representatives
African Region
Dr Mphu Ramatlapeng
Minister of Health
Ministry of Health
Lesotho
High-TB-burden Countries
American Region
Dr Meliton Arce Rodriguez
Deputy Minister of Health
Ministry of Health
Av. Salaverry cdra.8
Jesus Maria, Lima
Peru
Eastern Mediterranean Region
Dr Faizullah Kakar (unable to attend)
Deputy Minister of Policy, Planning and
Preventive Medicine
Ministry of Public Health
Afghanistan
Great Masoud Road
Kabul
Afghanistan
Represented by:
S.E. Mr Abdallah Abdillahi
Miguil
Minister of Health
Djibouti
European Region
Dr Tonka Varleva
Director
Prevention and Control of HIV/AIDS &
TB Directorate
Ministry of Health
Bulgaria
South-East Asia Region
Ms K.Sujatha Rao (unable to attend)
Secretary
Health and Family Welfare
Government of India
Nirman Bhavan
New Delhi 110011
China
Dr Xiao Donglou
Deputy Director General
Bureau of Disease Prevention and Control
Ministry of Health
1, Xi Zhi Men Wai Nan Lu
People's Republic of China
Myanmar
Professor Kyaw Myint (unable to attend)
Minister of Health
Ministry of Health
Myanmar
Represented by:
Dr Win Myint
Director General
Department of Health
Ministry of Health
South Africa
Represented by:
Dr Yogan Pillay (unable to attend)
Deputy Director-General
Department of Health
Private Bag X399
Pretoria
0001 South Africa
Tanzania
Professor David H. Mwakyusa
Minister for Health and
Social Welfare
Ministry of Health and Social Welfare
PO Box 9083
Dar es Salaaam
Republic of Tanzania
Multi-lateral Organizations
Western Pacific Region
Dr Nobukatsu Ishikawa(unable to attend)
Director
Research Institute for TB
Japan Anti-Tuberculosis Association (JATA)
3-1-24 Matsuyama, Kiyose
204 0022 - Tokyo
Japan
Represented by:
Dr Akira Shimouchi
Vice Director
Research Institute for TB
Japan Anti-Tuberculosis Association (JATA)
Global Fund to Fight Aids, TB and Malaria
Dr Rifat Atun
Director
Strategy, Performance & Evaluation Cluster
Switzerland
United Nations Programme on HIV/AIDS
Dr Catherine Hankins
Chief Scientific Adviser to UNAIDS
and Associate Director
Department of Evidence,
Monitoring and Policy
United Nations Programme on HIV/AIDS
20 avenue Appia, CH 1211
Geneva 27
Switzerland
World Health Organization
Dr Mario Raviglione
Director, STB Department
HIV/AIDS, Tuberculosis and Malaria (HTM)
World Health Organization (WHO)
20, avenue Appia
Geneva 27 1211
Switzerland
World Bank
Mr Julian Schweitzer (unable to attend)
Director of Health, Nutrition and Population
Human Development Network
The World Bank
1818 H Street, NW
Washington, DC 20433
United States of America
Represented by:
Ms. Montserrat Meiro-Lorenzo
Senior Public Health Specialist
The World Bank
Japan — Ministry of Health, Labour
and Welfare
Dr Masato Mugitani (unable to attend)
Assistant Minister for Global Health,
Minister’s Secretariat
Ministry of Health, Labour and Welfare
1-2-2, Kasumigaseki, Chiyoda-ku
Tokyo 100-8916, JAPAN
Represented by:
Dr Mari Nagai
Deputy Director
The Netherlands
Dr Marja Esveld
Senior Policy Advisor - Health
Gender and Civil Society
Department (DSI/SB)
Ministry of Foreign Affairs
PO Box 20061
2500 EB The Netherlands
United States Agency for International
Development (USAID)
Ms Irene Koek (Chair)
Chief, Infectious Diseases Division
Office of Health and Nutrition
Ronald Reagan Building
G/PHN/HN/EH
3.07-75M, 3rd floor, RRB
20523-3700 Washington D.C.
United States of America
Foundations
Bill & Melinda Gates Foundation
Dr Peter M. Small (unable to attend)
Senior Program Officer, Tuberculosis
Global Health Program
PO Box 23350
Seattle, WA 98102
United States of America
Represented by:
Mr Michael Kimerling
Senior Program Officer, Tuberculosis
Global Health Program
The Gates Foundation
Donors
Canadian International Development
Agency (CIDA)
Dr Ernest R. Loevinsohn
Director-General
Program Against Hunger, Malnutrition
and Disease
Multilateral Programs Branch
200, Promenade du Portage
Hull, Quebec K1A 0G4, Canada
Represented by:
Ms Christina Foley
TB Programme Officer
Health and Nutrition Directorate (HAND)
200 Promenade Ave, du Portage
Gatineau
KIA 0G4 - Quebec
Canada
Corporate business sector
BioMèrieux
Mr Jean Francois de Lavison
International Affairs and Public Relation
Vice President
c/o Mérieux Alliance
17 rue Bourgelat
69009 Lyon
France
Communities Affected by TB
Mr Pervaiz Tufail (unable to attend)
Director
National Group of TB People-Pakistan
Flat 6, Block 1, PHA Flats
G-7/2
44000-Islamabad
Pakistan
Ms Carol Nawina Nyirenda (unable to attend)
1st Floor, Sanctuary House
9th Street, Kabwata
Lusaka
10101 Zambia
Represented by:
Mr Mayowa Joel
Program Director
Communication for Development Centre
Lagos
Nigeria
NGOS and Technical Agencies
Centers for Disease Control and
Prevention
RADM Kenneth G. Castro, M.D.
Assistant Surgeon General, USPHS &
CDC/ATSDR Lead, Commissioned Corps
Director, Division of Tuberculosis Elimination
National Center for HIV, STD, and TB
Prevention Coordinating Center for Infectious
Diseases
Centers for Disease Control and Prevention,
Department of Health and Human Services
The Union
Dr Nils Billo (unable to attend)
Executive Director
International Union Against Tuberculosis and
Lung Disease
France
Represented by
Dr Paula Fujiwara
Deputy Executive Director
KNCV
Dr Peter Gondrie
Executive Director
The Hague
The Netherlands
Operation ASHA
Mr Sandeep Ahuja
Chief Executive Officer
New Delhi
India
Special Invitees
UN Secretary General's Special Envoy
to Stop TB & Former President of the
Portuguese Republic
Dr Jorge Sampaio
Casa do Regalo
Tapada das Necessidades
1350-213 Lisbon
Portugal
Ms Helena Barroco
Office of the UN Secretary General's
Special Envoy
Portugal
UNAIDS
Mr Michel Sidibé
Executive Director
Joint United Nations Programme
on HIV/AIDS (UNAIDS)
Geneva
Other invitees/Observers
International Labour Organization
Dr Sophia Kisting
Director
Global Programme on AIDS
Mr Kofi Amekudzi
Technical Officer
Global Programme on Aids
ASTRA ZENECA
Mr Matti Ojanen
Corporate business sector Alternate Board
Member &
Director, International Affairs &
Public Policy Group Public Affairs
London
United Kingdom
Stop TB Partnership Advocacy Advisory
Committee
Dr Lee B. Reichman
Executive Director
New Jersey Medical School Global
Tuberculosis Institute
PO Box 1709
225 Warren Street
Newark, NJ 07101-1709
Etats-Unis D'AMÉRIQUE
Ms Rachel A. Wilson
Director of Policy and Advocacy
Program for Appropriate Technology in
Health (PATH)
1800 K St. NW, Suite 800
Washington, DC 20006
Etats-Unis D'AMÉRIQUE
DFID
Mr Sajil Liaqat
Public Health Advisor
Human Development Group
1 Palace Street London SW1E 5HE
GATES Foundation
Ms Alexandra Melby Farnum
Program Officer
Global Health Policy & Advocacy
Johns Hopkins School of Medicine
Professor William Bishai, MD, PhD
Co-Chair, Working Group on New TB Drugs
& Co-Director
Center for Tuberculosis Research
Department. of Medicine
Division. of Infectious Diseases
Johns Hopkins School of Medicine
1550 Orleans St. Room 108
Baltimore, MD 21231-1001
United States of America
Kochon Foundation
Mr Baik In Hyun
Seoul
Republic of Korea
US Agency for International Development
Ms Susan Bacheller
TB Team Leader
Office of Health, Infectious Diseases
& Nutrition
Bureau for Global Health
3.06-80, 3rd floor
Ronald Reagan Building
Washington, DC 20523-5900
United States of America
UNDP
Dr Sabine Beckmann
Senior Programme Advisor
HIV/AIDS Group
Bureau for Development Policy
UNDP Office in Geneva
Switzerland
UNITAID
Dr Jorge Bermudez
Executive Secretary
Switzerland
Myanmar
Dr Win Maung
Director (Disease Control)
Department of Health
Ministry of Health
The Union of Myanmar
Aeras Global TB Vaccine Foundation
Ms Jennifer Woolley
Director, Advocacy and Resource
Mobilization
Aeras Global TB Vaccine Foundation
Rockville, MD USA
McKinsey & Company
Farhad Riahi
Boris Ewenstein
Arjen Iwema
Dr Jaap F. Broekmans
Former Executive Director KNCV
Koningin Emmakade 174
2518 JN - The Hague
PAYS-BAS
Ms Karin Holm
Independent Consultant
Geneva
WHO AFRO
Dr Rufaro. Chatora
Director
Division of Prevention and Control of AIDS,
TB and Malaria
WHO EMRO
Dr.Akihiro Seita
Regional Adviser, TB
WHO EURO
Dr Lucica Ditiu
Medical Officer
WHO/Headquarters
20, avenue Appia
Geneva 27, 1211, Switzerland
Dr.Hiroki Nakatani
Assistant Director General
HIV/AIDS, Tuberculosis, Malaria and
Neglected Tropical Diseases (HTM)
Dr Hans V. Hogerzeil
Director
Essential Medicines and Pharmaceutical
Policies
Dr Leopold Blanc
Coordinator, Stop TB Strategy
Stop TB Department
Dr Katherine Floyd
Coordinator, TB Monitoring and Evaluation
Stop TB Department
Dr Paul Nunn
TB Operations and Coordination
Stop TB Department
Ms Diana Weil
Coordinator, Policy and Strategy
Stop TB Department
Dr. Karin Weyer
Coordinator, TB Laboratory Strengthening
Stop TB Department
Stop TB Partnership Secretariat
Hosted and administered by WHO
20, avenue Appia
Geneva 27, 1211, Switzerland
Dr Marcos Espinal
Executive Secretary
Ms Louise Baker
Senior Strategist
Ms Julia Geer
Team Leader, Branding, Marketing,
Communications
Dr Giuliano Gargioni
Team Leader, Partnering & Social
Mobilization
Mr Anant Vijay
Department & Partnership Resource
Administrator
Mr Tom Moore
Interim Chief Operating Officer, GDF
Dr Christian Liendhardt
Research Movement
Mr Alan Esser
Governance Officer
Mr Homero Hernandez
Global Advocacy & Resource
Mobilization Officer
Stop TB Coordinating Board meeting, Geneva, Switzlerand, 5-6 November 2009